Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03623367v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia
M-A Hospital
,
A. Jacquel
,
F Mazed
,
E Saland
,
C. Larrue
et al.
Journal articles
hal-02365710v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Rapamycin inhibits growth and survival of D-816-V-mutated c-kit mast cells
M. Gabillot-Carré
,
Y. Lepelletier
,
M. Humbert
,
P. de Sepuvelda
,
N. Ben Hamouda
et al.
Blood , 2006, 108, pp.1065-1072
Journal articles
hal-00022484v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.
S. Park
,
N. Chapuis
,
Franck Saint-Marcoux
,
C. Recher
,
T. Prebet
et al.
Journal articles
hal-00849677v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs
G. Bossis
,
J. E. Sarry
,
C. Kifagi
,
M. Ristic
,
E. Saland
et al.
Journal articles
hal-02191559v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Autologus stern celle transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloisdosis : results of the French multicentric randomized trial (MAG and IFM intergroup).
Arnaud Jaccard
,
P. Moreau
,
V. Leblond
,
X. Leleu
,
L Bennoubker
et al.
Communication orale présentée à 'The American Society of Hematology 47th Annual meeting and Exposition" , Dec 2005, Nouvelle Orléans (Louisiane), United States
Conference papers
hal-01135622v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
et al.
Journal articles
hal-03376715v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
Mathilde Hunault-Berger
,
N. Maillard
,
C. Himberlin
,
C. Recher
,
Aline Schmidt-Tanguy
et al.
Journal articles
inserm-01814864v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis
C. Bulai Livideanu
,
Pol‐andré Apoil
,
B. Lepage
,
M. Eischen
,
C. Laurent
et al.
Journal articles
istex
hal-03444089v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
C. Berthon
,
E. Raffoux
,
X. Thomas
,
N. Vey
,
C. Gomez-Roca
et al.
Journal articles
hal-01791279v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells
S. Scotland
,
E. Saland
,
N. Skuli
,
Fabienne de Toni
,
H. Boutzen
et al.
Journal articles
hal-02650325v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More